Protease Inhibitor Cocktail, mini-Tablet (EDTA-Free)

Cat# HY-K0011-50pcs

Size : 50pcs

Marca : MedChemExpress

Contatta il distributore locale :


Telefono : +1 850 650 7790
Protease Inhibitor Cocktail, mini-Tablet

Protease Inhibitor Cocktail, mini-Tablet  (EDTA-Free)

Cat. No.: HY-K0011
Manual COA SDS

Protease inhibitor cocktail is used in cell lysates or tissue extracts to increase protein stability.

Protease Inhibitor Cocktail, mini-Tablet
or

* Veuillez sélectionner la quantité avant d'ajouter des articles.

Protease Inhibitor Cocktail, mini-Tablet Recommandations en vedette:

  • Protease Inhibitor Cocktail
  • Phosphatase Inhibitor Cocktail I
  • Phosphatase Inhibitor Cocktail II
  • Phosphatase Inhibitor Cocktail III
  • Deacetylase Inhibitor Cocktail (100× in 70% DMSO)
  • Protein A/G Magnetic Beads
  • Magnetic Stand
  • Anti-HA Magnetic Beads
  • Streptavidin Magnetic Beads
  • Protein A Magnetic Beads
  • Description

  • Stockage

  • Protocole

  • Composants

  • Documentation

Endogenous proteins are produced and removed in a balanced state, so their cellular levels are generally stable under stable environmental conditions. However, protein production is greatly halted and degradation is enhanced when cells are studied in vitro. To prevent the degradation of proteins under such conditions, one can utilize a cocktail of small molecule inhibitors to block the action of proteases. Generally, protease inhibitor cocktails are used in cell lysates or tissue extracts to increase protein stability. As the name indicates, the cocktail functions to inhibit proteases that would degrade either phosphorylated or non-phosphorylated protein substrates. MedChemExpress Protease Inhibitor Cocktail (EDTA free, mini-Tablet) is a blend of 5 pan-protease inhibitors for protection of protein integrity.

  • Signal Transduct Target Ther. 2023 Oct 23;8(1):404.  [Abstract]
  • Signal Transduct Target Ther. 2021 Sep 4;6(1):333.  [Abstract]
  • Cell Discov. 2021 Jun 22;7(1):46.  [Abstract]
  • Cell Res. 2021 Mar;31(3):345-361.  [Abstract]
  • Cell. 2020 Apr 30;181(3):621-636.e22.  [Abstract]
  • Nat Metab. 2023 May 15.  [Abstract]
  • Sci Immunol. 2022 Feb 4;7(68):eabk2092.  [Abstract]
  • Cell Mol Immunol. 2021 Mar 11.  [Abstract]
  • Adv Sci (Weinh). 2022 Oct 30;e2204697.  [Abstract]
  • Adv Funct Mater. 2020, 2004886.
  • Nucleic Acids Res. 2023 Mar 20;gkad197.  [Abstract]
  • J Hazard Mater. 5 October 2022, 129689.
  • Cell Rep Med. 2022 Mar 15;3(3):100561.  [Abstract]
  • Cell Rep Med. April 20, 2022.
  • Engineering. 14 August 2021.
  • Mol Ther. 2021 Jun 7;S1525-0016(21)00312-9.  [Abstract]
  • Exp Hematol Oncol. 2021 Jun 4;10(1):35.  [Abstract]
  • EMBO J. 2021 May 19;e106183.  [Abstract]
  • Acta Pharm Sin B. 2021 Jun;11(6):1592-1606.  [Abstract]
  • Sci Adv. 2021 Mar 3;7(10):eabe8591.  [Abstract]
  • Theranostics. 2021 Mar 4;11(10):4825-4838.  [Abstract]
  • Acta Pharm Sin B. 2020 Dec 15.
  • Theranostics. 2021 Jan 1;11(2):925-940.  [Abstract]
  • EMBO Mol Med. 2020 Dec 7;e12798.  [Abstract]
  • Theranostics. 2020 Oct 30;10(26):12223-12240.  [Abstract]
  • J Exp Clin Cancer Res. 2020 Oct 21;39(1):222.  [Abstract]
  • Theranostics. 2020 Aug 2;10(21):9830-9842.  [Abstract]
  • Theranostics. 2020 Jul 11;10(19):8834-8850.  [Abstract]
  • Environ Int. 2020 Aug;141:105755.  [Abstract]
  • Hortic Res. 2024 Mar 6.
  • Cell Rep. 2023 Jun 22;42(7):112691.  [Abstract]
  • Hortic Res. 2023 May 4.
  • Pharmacol Res. 2023 Apr 15;106773.  [Abstract]
  • Environ Pollut. 2022 Oct 17;120446.  [Abstract]
  • Cell Rep. 2021 Nov 16;37(7):110025.  [Abstract]
  • Cancer Lett. 20 October 2021.
  • Cell Death Dis. 2021 Jun 2;12(6):570.  [Abstract]
  • J Colloid Interf Sci. 2021 May 24.
  • New Phytol. 2021 May 27.  [Abstract]
  • Cell Prolif. 2021 May 5;e13045.  [Abstract]
  • Cell Commun Signal. 2021 May 20;19(1):58.  [Abstract]
  • Int J Biol Sci. 2021 Mar 21;17(5):1234-1249.  [Abstract]
  • Cell Prolif. 2021 Apr 8;e13039.  [Abstract]
  • Cell Death Dis. 2021 Mar 17;12(4):284.  [Abstract]
  • ACS Appl Mater Interfaces. 2020 Oct 21;12(42):47330-47341.  [Abstract]
  • Chemosphere. 2021 Jan;262:127891.  [Abstract]
  • J Neuroinflammation. 2020 May 6;17(1):150.  [Abstract]
  • Int J Biol Sci. 2021 Jan 1;17(1):339-352.  [Abstract]
  • Cell Death Dis. 2020 May 11;11(5):351.  [Abstract]
  • Cell Rep. 2019 Jun 18;27(12):3684-3695.e4.   [Abstract]
  • J Med Chem. 2022 Aug 31.  [Abstract]
  • JCI Insight. 2022 Feb 22;7(4):e149626.  [Abstract]
  • J Transl Med. 2021 Sep 20;19(1):396.  [Abstract]
  • J Invest Dermatol. 2021 Sep 14;S0022-202X(21)01672-9.  [Abstract]
  • Cell Biosci. 2021 Jun 30;11(1):118.  [Abstract]
  • Eur J Med Chem. 2021, 113605.
  • Biomater Sci. 2021 May 10.  [Abstract]
  • Free Radic Biol Med. 2021 Jan 12;S0891-5849(20)32114-6.  [Abstract]
  • Cell Death Discov. 2021 Jan 11;7(1):3.  [Abstract]
  • Neural Regen Res. 2021 Jul;16(7):1308-1316.  [Abstract]
  • Mol Ther-Nucl Acids. 2020 Oct 4;22:708-721.  [Abstract]
  • PLoS Pathog. 2020 Oct 16;16(10):e1009002.  [Abstract]
  • Phytomedicine. 2020, Jul 28.
  • Antioxidants. 2020 Aug 22;9(9):780.  [Abstract]
  • Life Sci. 2020 Oct 15;259:118159.  [Abstract]
  • Talanta. 2020 Nov 1;219:121281.  [Abstract]
  • Biomed Pharmacother. 2020 Aug;128:110216.  [Abstract]
  • iScience. 2023 Jul 27.
  • J Proteome Res. 2023 Jun 7.  [Abstract]
  • J Biol Chem. 2023 Apr 17;104723.  [Abstract]
  • J Cell Physiol. 2023 Feb 15.  [Abstract]
  • Cells. 2022 Nov 14;11(22):3602.  [Abstract]
  • Viruses. 2022, 14(11), 2349.
  • Int J Mol Sci. 2022 May 9;23(9):5259.  [Abstract]
  • Cells. 2022 Feb 26;11(5):817.  [Abstract]
  • iScience. 2022 Mar 1;25(4):104009.  [Abstract]
  • Bioorg Chem. May 2022, 105714.
  • Viruses. 2022, 14(3), 514.
  • Cells. 2022, 11(3), 447.
  • Viruses. 2022 Feb 15;14(2):394.  [Abstract]
  • Reprod Biol Endocrinol. 2022 Feb 2;20(1):25.  [Abstract]
  • FASEB J. 2022 Feb;36(2):e22124.  [Abstract]
  • Int Immunopharmacol. 2021 Dec 16;103:108430.  [Abstract]
  • Int J Mol Sci. 2021 Aug 26;22(17):9245.  [Abstract]
  • Neurochem Int. 2021, 105152.
  • Acs Biomater Sci Eng. 2021 Jun 30.  [Abstract]
  • Front Cell Dev Biol. 2021 Jul 8;9:689727.  [Abstract]
  • Commun Biol. 2021 Jun 23;4(1):777.  [Abstract]
  • iScience. 2021, 102770.
  • Clin Epigenetics. 2021 Jun 10;13(1):127.  [Abstract]
  • Front Pharmacol. 24 June 2021.
  • J Cell Physiol. 2021 May 27.  [Abstract]
  • J Virol. 2021 May 19;JVI.00563-21.  [Abstract]
  • Bioorg Chem. 2021 Aug;113:104981.  [Abstract]
  • Int Immunopharmacol. 2021, 107785.
  • Front Pharmacol. 20 May 2021.
  • Commun Biol. 2021 Apr 22;4(1):491.  [Abstract]
  • Biochem Pharmacol. 2021, 114542.
  • J Ethnopharmacol. 2021 Apr 20;114061.  [Abstract]
  • Am J Cancer Res. 2021 Mar 1;11(3):930-944.  [Abstract]
  • J Biol Chem. Jan-Jun 2021;296:100614.  [Abstract]
  • J Biol Chem. 2021, 100616.
  • Oncol Rep. 2021 Apr 13.
  • Int Immunopharmacol. 2021, 107342.
  • Molecules. 2021, 26(6), 1580.
  • Cancer Sci. 2020 Nov;111(11):4142-4153.  [Abstract]
  • J Biol Chem. 2021 Feb 2;100369.  [Abstract]
  • Mol Cell Endocrinol. 2021 Feb 23;111218.  [Abstract]
  • Cancer Sci. 2020 Nov;111(11):4102-4117.  [Abstract]
  • Int J Mol Med. 2021 Jan;47(1):171-182.  [Abstract]
  • J Mol Cell Cardiol. 2020 Dec;149:82-94.  [Abstract]
  • Pharmaceutics. 2020 Oct 9;12(10):950.  [Abstract]
  • Regen Ther. 2020 Oct 16;15:202-209.  [Abstract]
  • Neurobiol Aging. 2021 Feb;98:10-20.  [Abstract]
  • Am J Chin Med. 2020;48(6):1369-1383.  [Abstract]
  • J Drug Deliv Sci Technol. 2020, 102048.
  • Viruses. 2020 Sep 2;12(9):974.  [Abstract]
  • Sci Rep. 2020 Aug 3;10(1):13063.  [Abstract]
  • Inflammation. 2020 Oct;43(5):1862-1875.  [Abstract]
  • Zool Res. 2020 Sep 18;41(5):527-538.  [Abstract]
  • Inflammation. 2020 Oct;43(5):1772-1779.  [Abstract]
  • ACS Chem Neurosci. 2020 Jun 3;11(11):1682-1691.  [Abstract]
  • Chem Commun (Camb). 2020 Jan 30;56(9):1389-1392.  [Abstract]
  • Drug Des Devel Ther. 2020 May 18;14:1897-1908.  [Abstract]
  • J Fungi (Basel). 2020 Jun 3;6(2):77.  [Abstract]
  • Int J Mol Med. 2020 Aug;46(2):718-728.  [Abstract]
  • Eur J Pharm Sci. 2020 Aug 1;151:105402.  [Abstract]
  • J Drug Target. 2020 May 4:1-26.  [Abstract]
  • Invest Ophthalmol Vis Sci. 2020 Apr 9;61(4):48.  [Abstract]
  • Biochim Biophys Acta Gen Subj. 2024 Mar 9:130595.  [Abstract]
  • Brain Sci. 2023, 13(2), 262.
  • Neurotoxicology. 28 October 2022.
  • Placenta. 2022 Jan 10;118:55-65.  [Abstract]
  • Mol Brain. 2022 Jan 3;15(1):4.  [Abstract]
  • Insects. 2021, 12(9), 812.
  • Mol Med Rep. 2021 Aug;24(2):580.  [Abstract]
  • Dig Dis Sci. 2022 Jun;67(6):2220-2231.  [Abstract]
  • Cancer Med. 2021 May 7.  [Abstract]
  • Mol Biol Rep. 2021 May 18.  [Abstract]
  • J Orthop Surg Res. 2021 May 5;16(1):297.  [Abstract]
  • J Cancer. 2021 Apr.
  • Biochem Biophys Res Commun. 2021 Apr 8;556:127-133.  [Abstract]
  • Cancer Med. 2021 Apr;10(7):2470-2481.  [Abstract]
  • BMC Complement Med Ther. 21, 88 (2021).
  • Theriogenology. 2021 Mar 19.
  • Breast Cancer. 2021 Jul;28(4):859-873.  [Abstract]
  • Infect Immun. 2021 Feb 1;IAI.00696-20.  [Abstract]
  • Biochem Biophys Res Commun. 2021 Feb 3;545:105-111.  [Abstract]
  • Oncol Lett. 2021 Feb;21(2):117.  [Abstract]
  • Infect Immun. 2020 Oct 19;88(11):e00537-20.  [Abstract]
  • J Gen Virol. 2020 Nov;101(11):1145-1155.  [Abstract]
  • Biochem Bioph Res Co. 2020 Sep 10;530(1):160-166.  [Abstract]
  • Biochem Bioph Res Co. 2020 Jul 30;528(3):485-492.  [Abstract]
  • Vet Microbiol. 2020 Jun;245:108709.  [Abstract]
  • Vet Microbiol. 2020 Jun;245:108707.  [Abstract]
  • Biochem Biophys Res Commun. 2020 Jul 12;528(1):105-111.  [Abstract]
  • Toxicol In Vitro. 2020 Jun;65:104825.  [Abstract]
  • Acta Neurobiol Exp. 2022, 82.
  • Xenobiotica. 2021 Aug 12;1-25.  [Abstract]
  • Protein Expres Purif. 2021, 105860.
  • J Interv Card Electrophysiol. 2021 Feb 20.  [Abstract]
  • J Gen Appl Microbiol. 2021 Apr 16;67(1):33-41.  [Abstract]
  • Int J Med Mushrooms. 2020;22(10):979-990.  [Abstract]
  • SSRN. 2024 Feb 6.
  • Research Square Preprint. 2023 Nov 9.
  • bioRxiv. 2023 Aug 15.
  • Research Square Preprint. 2023 Jun 21.
  • Research Square Preprint. 2022 May.
  • Research Square Preprint. 2022 Feb.
  • Leuk Res. December 2021, 106708.
  • Research Square Preprint. 2021 Aug.
  • Health Sci J. (2021): 1-7.
  • Methods Mol Biol. 2021;2348:231-242.  [Abstract]
  • Research Square Preprint. 2021 Jun.
  • Research Square Preprint. 2021 May.
  • Biomed Res Int. 2021 Apr 16.
  • Bezmialem Science. 2021;9(2):164-70.
  • Research Square Preprint. 2021 Mar.
  • Research Square Preprint. 2021 Mar.
  • SSRN. 2021 Jan 26.
  • Research Square Preprint. 2020 Oct.
  • Research Square Preprint. 2020 Dec.
  • Mediat Inflamm. 2020 Oct 15;2020:4346367.  [Abstract]
  • Preprints. 2020, 2020090120.
  • Research Square Preprint. 2020 Sep.
  • Evid Based Complement Alternat Med. 2020 Oct 30;2020:8894257.  [Abstract]
  • bioRxiv. 2020 Jul.
Protease Inhibitor Cocktail (EDTA free, mini-Tablet) can be stored at 4°C for 2 years.

1. This product can be applied in Western Blot analysis, Co-IP, pull-down, IF, IHC, kinase assay and etc.
2. One mini-Tablet can be added to 10mL extraction medium directly. Alternatively, a stock solution (10X conc. one mini-Tablet in 1mL ddH2O) can be prepared. Vortex briefly to accelerate the dissolution. The stock solution is stable for one week when stored at 4°C, and for at least 4 weeks at -20°C.

Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Vos produits récemment consultés:

Bulk Inquiry

Your information is safe with us. * Required Fields.

Bulk Inquiry

Inquiry Information

Nom du produit:
Protease Inhibitor Cocktail, mini-Tablet
Cat. No.:
HY-K0011
Quantité:
MCE Japan Authorized Agent:

Si può anche essere interessati nei seguenti prodotti:



Cat#
Descrizione
Cond.
Priced